EGFR and chronic myelogenous leukemia, BCR-ABL1 positive: Another attribute of some well-known oncogenes, such as BCR-ABL fusion in chronic myeloid leukemia or mutant EGFR or KRAS in LUAD, is the dependence on sustained expression of those oncogenes for the maintenance of cell growth or viability.